Clinical Trials
Trial Assigning Individualized Options for Treatment (Rx) (TAILORx):
The TAILORx trial is designed to determine whether adjuvant hormonal therapy alone is as effective as adjuvant hormonal therapy in combination with chemotherapy for certain women with breast cancer. Trial results will help individualize treatment for each breast cancer patient, for improved clinical outcomes.
Women must have estrogen receptor- and/or progesterone receptor-positive, axillary node-negative, HER2/neu-negative breast cancer. The tumor size must be 1.1 to 5.0 cm (or 5.0 mm to 1.0 cm, with unfavorable histological features). Participants must meet standard clinical criteria and be medically suitable candidates for adjuvant chemotherapy.
If Oncotype is not covered by the patient insurance, it will be provided at no cost.
For more information or to have a patient screened, contact the TAILORx Study Coordinator at 713-798-1911 or 713-798-9143.